Document is current
Any future updates will be listed below
-
Authors
Fernández-Cisneros, A.
Hernández-Meneses, M.
Llopis, J.
Sandoval, E.
Pereda, D.
Alcocer, J.
Barriuso, C.
Castellá, M.
Ambrosioni, J.
Pericàs, J. M.
Vidal, B.
Falces, C.
Ibáñez, C.
Perdomo, J.
Rovira, I.
García-de-la-María, C.
Moreno, A.
Almela, M.
Perisinotti, A.
Dahl, A.
Castro, P.
Miró, J. M.
Quintana, E. https://orcid.org/0000-0002-5386-7463
,
-
Funding
Funding for this research was provided by:
Universitat de Barcelona
- License Information
-
More Information
Article History
Received: 30 June 2022
Accepted: 20 October 2022
First Online: 8 November 2022
Declarations
:
: Institutional review board approved the present clinical study and waived individual consent form (HCB/2018/0522).
: Institutional review board approved the present clinical study and waived individual consent form.
: Not applicable.
: JMM has received consulting honoraria and/or research grants from Angelini, Bristol-Myers Squibb, Contrafect, Genentech, Gilead Sciences, MSD, Medtronic, Novartis, Pfizer, and ViiV. All other authors: no conflicts.
